JP2009514980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009514980A5 JP2009514980A5 JP2008540217A JP2008540217A JP2009514980A5 JP 2009514980 A5 JP2009514980 A5 JP 2009514980A5 JP 2008540217 A JP2008540217 A JP 2008540217A JP 2008540217 A JP2008540217 A JP 2008540217A JP 2009514980 A5 JP2009514980 A5 JP 2009514980A5
- Authority
- JP
- Japan
- Prior art keywords
- diazabicyclo
- carbon atoms
- ylcarbonyl
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 106
- 229910005965 SO 2 Inorganic materials 0.000 claims 77
- 125000000217 alkyl group Chemical group 0.000 claims 52
- 150000001875 compounds Chemical class 0.000 claims 44
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 42
- 229910052794 bromium Inorganic materials 0.000 claims 39
- 229910052801 chlorine Inorganic materials 0.000 claims 39
- 229910052731 fluorine Inorganic materials 0.000 claims 39
- 229910052740 iodine Inorganic materials 0.000 claims 39
- -1 Cyano, Hydroxy Chemical group 0.000 claims 36
- 125000003545 alkoxy group Chemical group 0.000 claims 20
- 125000004663 dialkyl amino group Chemical group 0.000 claims 19
- 229910052736 halogen Inorganic materials 0.000 claims 19
- 150000002367 halogens Chemical class 0.000 claims 19
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 claims 13
- 125000004043 oxo group Chemical group O=* 0.000 claims 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 12
- 239000012453 solvate Substances 0.000 claims 11
- 150000001350 alkyl halides Chemical class 0.000 claims 10
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 9
- 239000012458 free base Substances 0.000 claims 9
- 229920006395 saturated elastomer Polymers 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 150000001204 N-oxides Chemical class 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000006413 ring segment Chemical group 0.000 claims 4
- CDQFTKBQYMHUKI-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-morpholin-4-yl-1h-indazol-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2N1CCOCC1 CDQFTKBQYMHUKI-UHFFFAOYSA-N 0.000 claims 3
- PGHTXZVHWVYKII-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-pyrrolidin-1-yl-1h-indazol-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2N1CCCC1 PGHTXZVHWVYKII-UHFFFAOYSA-N 0.000 claims 3
- XDLAJOHFJBFDBR-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-thiomorpholin-4-yl-1h-indazol-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2N1CCSCC1 XDLAJOHFJBFDBR-UHFFFAOYSA-N 0.000 claims 3
- YANZINWIXKAPBJ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(1,4-oxazepan-4-yl)-1h-indazol-3-yl]methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2N1CCCOCC1 YANZINWIXKAPBJ-UHFFFAOYSA-N 0.000 claims 3
- SDGFKGORCOJBTQ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(3-methoxypyrrolidin-1-yl)-1h-indazol-3-yl]methanone Chemical compound C1C(OC)CCN1C1=CC=C(C(=NN2)C(=O)N3C4CCN(CC4)CC3)C2=C1 SDGFKGORCOJBTQ-UHFFFAOYSA-N 0.000 claims 3
- BDJQBBPBWIKLPI-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(4-methyl-1,4-diazepan-1-yl)-1h-indazol-3-yl]methanone Chemical compound C1CN(C)CCCN1C1=CC=C(C(=NN2)C(=O)N3C4CCN(CC4)CC3)C2=C1 BDJQBBPBWIKLPI-UHFFFAOYSA-N 0.000 claims 3
- CZUBGJIEWJEYLG-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(4-methylpiperazin-1-yl)-1h-indazol-3-yl]methanone Chemical compound C1CN(C)CCN1C1=CC=C(C(=NN2)C(=O)N3C4CCN(CC4)CC3)C2=C1 CZUBGJIEWJEYLG-UHFFFAOYSA-N 0.000 claims 3
- KGLWXAZNCVRDSK-UHFFFAOYSA-N 1-[3-(1,4-diazabicyclo[3.2.2]nonane-4-carbonyl)-1h-indazol-6-yl]-3-propylimidazolidin-2-one Chemical compound O=C1N(CCC)CCN1C1=CC=C(C(=NN2)C(=O)N3C4CCN(CC4)CC3)C2=C1 KGLWXAZNCVRDSK-UHFFFAOYSA-N 0.000 claims 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 3
- FOPHMSZZCWXLSE-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-pyrrolidin-1-yl-1,2-benzothiazol-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NSC1=CC=2N1CCCC1 FOPHMSZZCWXLSE-UHFFFAOYSA-N 0.000 claims 2
- IVDYMQJQBOZDLZ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[5-(oxan-3-yloxy)-1h-indazol-3-yl]methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=C2)=NNC1=CC=C2OC1CCCOC1 IVDYMQJQBOZDLZ-UHFFFAOYSA-N 0.000 claims 2
- VKKAITWTUBGNFK-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[5-[4-(2,2,2-trifluoroethyl)-1,4-diazepan-1-yl]-1h-indazol-3-yl]methanone Chemical compound C1CN(CC(F)(F)F)CCCN1C1=CC=C(NN=C2C(=O)N3C4CCN(CC4)CC3)C2=C1 VKKAITWTUBGNFK-UHFFFAOYSA-N 0.000 claims 2
- IOUAQUSNNJXIFQ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(1-methyl-4,5-dihydroimidazol-2-yl)-1h-indazol-3-yl]methanone Chemical compound CN1CCN=C1C1=CC=C(C(=NN2)C(=O)N3C4CCN(CC4)CC3)C2=C1 IOUAQUSNNJXIFQ-UHFFFAOYSA-N 0.000 claims 2
- MODJKVLWMQXWNQ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(1-methylpyrrolidin-3-yl)oxy-1,2-benzothiazol-3-yl]methanone Chemical compound C1N(C)CCC1OC1=CC=C(C(=NS2)C(=O)N3C4CCN(CC4)CC3)C2=C1 MODJKVLWMQXWNQ-UHFFFAOYSA-N 0.000 claims 2
- XEKACKLBOIHKMY-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(4-methyl-1,4-diazepan-1-yl)-1,2-benzothiazol-3-yl]methanone Chemical compound C1CN(C)CCCN1C1=CC=C(C(=NS2)C(=O)N3C4CCN(CC4)CC3)C2=C1 XEKACKLBOIHKMY-UHFFFAOYSA-N 0.000 claims 2
- OTCDNWYAYRJYFI-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(4-methylpiperazin-1-yl)-1,2-benzothiazol-3-yl]methanone Chemical compound C1CN(C)CCN1C1=CC=C(C(=NS2)C(=O)N3C4CCN(CC4)CC3)C2=C1 OTCDNWYAYRJYFI-UHFFFAOYSA-N 0.000 claims 2
- OPBMDLXCLRKRON-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(5-methyl-2,5-diazabicyclo[2.2.2]octan-2-yl)-1,2-benzothiazol-3-yl]methanone Chemical compound CN1CC2CCC1CN2C(C=C1SN=2)=CC=C1C=2C(=O)N1CCN2CCC1CC2 OPBMDLXCLRKRON-UHFFFAOYSA-N 0.000 claims 2
- BHNLNIXBMVMWBJ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(oxan-3-yloxy)-1h-indazol-3-yl]methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2OC1CCCOC1 BHNLNIXBMVMWBJ-UHFFFAOYSA-N 0.000 claims 2
- UKVXPHCQATZHCH-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-(oxan-4-yloxy)-1h-indazol-3-yl]methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2OC1CCOCC1 UKVXPHCQATZHCH-UHFFFAOYSA-N 0.000 claims 2
- YYMONJYIJHVWEZ-IAGOWNOFSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-[(1r,4r)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazol-3-yl]methanone Chemical compound C([C@@]1(N(C[C@@]2([H])C1)C)[H])N2C(C=C1SN=2)=CC=C1C=2C(=O)N1CCN2CCC1CC2 YYMONJYIJHVWEZ-IAGOWNOFSA-N 0.000 claims 2
- YYMONJYIJHVWEZ-IRXDYDNUSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazol-3-yl]methanone Chemical compound C([C@]1(N(C[C@]2([H])C1)C)[H])N2C(C=C1SN=2)=CC=C1C=2C(=O)N1CCN2CCC1CC2 YYMONJYIJHVWEZ-IRXDYDNUSA-N 0.000 claims 2
- DXGBMYLWFPPWLO-MRXNPFEDSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazol-3-yl]methanone Chemical compound C1[C@H](OC)CCN1C1=CC=C(C(=NS2)C(=O)N3C4CCN(CC4)CC3)C2=C1 DXGBMYLWFPPWLO-MRXNPFEDSA-N 0.000 claims 2
- DXGBMYLWFPPWLO-INIZCTEOSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-[6-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazol-3-yl]methanone Chemical compound C1[C@@H](OC)CCN1C1=CC=C(C(=NS2)C(=O)N3C4CCN(CC4)CC3)C2=C1 DXGBMYLWFPPWLO-INIZCTEOSA-N 0.000 claims 2
- 125000005330 8 membered heterocyclic group Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- 101100349077 Caenorhabditis elegans nrf-6 gene Proteins 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- HPELPVSEHNCJLX-UHFFFAOYSA-N [6-(3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl)-1,2-benzothiazol-3-yl]-(1,4-diazabicyclo[3.2.2]nonan-4-yl)methanone Chemical compound N=1SC2=CC(N3CC4CCCN4CC3)=CC=C2C=1C(=O)N1CCN2CCC1CC2 HPELPVSEHNCJLX-UHFFFAOYSA-N 0.000 claims 2
- AZIYSLGXZWNCRO-OALUTQOASA-N [6-[(1s,4s)-5-cyclopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazol-3-yl]-(1,4-diazabicyclo[3.2.2]nonan-4-yl)methanone Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N2C3CCN(CC3)CC2)C[C@@]2(C1)[H])[H])N2C1CC1 AZIYSLGXZWNCRO-OALUTQOASA-N 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000005110 aryl thio group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 2
- 125000005959 diazepanyl group Chemical group 0.000 claims 2
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- LNPMTXRDMQWIPO-OALUTQOASA-N tert-butyl (1s,4s)-5-[3-(1,4-diazabicyclo[3.2.2]nonane-4-carbonyl)-1,2-benzothiazol-6-yl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate Chemical compound C([C@]1(N(C[C@]2([H])C1)C(=O)OC(C)(C)C)[H])N2C(C=C1SN=2)=CC=C1C=2C(=O)N1CCN2CCC1CC2 LNPMTXRDMQWIPO-OALUTQOASA-N 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- YRXUTSNTOGXCAG-UHFFFAOYSA-N 1,2-benzothiazol-3-yl(1,4-diazabicyclo[3.2.2]nonan-4-yl)methanone Chemical compound N=1SC2=CC=CC=C2C=1C(=O)N1CCN2CCC1CC2 YRXUTSNTOGXCAG-UHFFFAOYSA-N 0.000 claims 1
- FZSKECBLOWFYPD-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(1-ethyl-6-methoxyindazol-3-yl)methanone Chemical compound C12=CC=C(OC)C=C2N(CC)N=C1C(=O)N1CCN2CCC1CC2 FZSKECBLOWFYPD-UHFFFAOYSA-N 0.000 claims 1
- JOQVMBXCUQJRSB-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-phenyl-2h-pyrazolo[3,4-b]pyridin-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=NC=2C1=CC=CC=C1 JOQVMBXCUQJRSB-UHFFFAOYSA-N 0.000 claims 1
- CHVCZOHUBWQHTK-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(6-phenylmethoxy-1h-indazol-3-yl)methanone Chemical compound C1CN(CC2)CCC2N1C(=O)C(C1=CC=2)=NNC1=CC=2OCC1=CC=CC=C1 CHVCZOHUBWQHTK-UHFFFAOYSA-N 0.000 claims 1
- VXAYFZPZFVZCPZ-UHFFFAOYSA-N 1,4-diazabicyclo[3.2.2]nonan-4-yl-(7-fluoro-6-methoxy-1,2-benzothiazol-3-yl)methanone Chemical compound N=1SC2=C(F)C(OC)=CC=C2C=1C(=O)N1CCN2CCC1CC2 VXAYFZPZFVZCPZ-UHFFFAOYSA-N 0.000 claims 1
- LLSRLLPHUVVLQJ-UHFFFAOYSA-N 1-cycloheptyldiazepane Chemical group C1CCCCCC1N1NCCCCC1 LLSRLLPHUVVLQJ-UHFFFAOYSA-N 0.000 claims 1
- PPNCOQHHSGMKGI-UHFFFAOYSA-N 1-cyclononyldiazonane Chemical group C1CCCCCCCC1N1NCCCCCCC1 PPNCOQHHSGMKGI-UHFFFAOYSA-N 0.000 claims 1
- NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical group C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 claims 1
- 229910014033 C-OH Inorganic materials 0.000 claims 1
- 229910014570 C—OH Inorganic materials 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- DOGJICDABWIVPC-BBRMVZONSA-N [6-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazol-3-yl]-(1,4-diazabicyclo[3.2.2]nonan-4-yl)methanone Chemical compound C([C@]1(NC[C@]2([H])C1)[H])N2C(C=C1SN=2)=CC=C1C=2C(=O)N1CCN2CCC1CC2 DOGJICDABWIVPC-BBRMVZONSA-N 0.000 claims 1
- OXDKBEYNLGGKKV-PMACEKPBSA-N [6-[(1s,4s)-5-(cyclopropylmethyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazol-3-yl]-(1,4-diazabicyclo[3.2.2]nonan-4-yl)methanone Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N2C3CCN(CC3)CC2)C[C@@]2(C1)[H])[H])N2CC1CC1 OXDKBEYNLGGKKV-PMACEKPBSA-N 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002636 imidazolinyl group Chemical group 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000005961 oxazepanyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73476105P | 2005-11-09 | 2005-11-09 | |
| PCT/US2006/043818 WO2007056582A1 (en) | 2005-11-09 | 2006-11-09 | 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009514980A JP2009514980A (ja) | 2009-04-09 |
| JP2009514980A5 true JP2009514980A5 (https=) | 2009-11-26 |
Family
ID=37745197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008540217A Pending JP2009514980A (ja) | 2005-11-09 | 2006-11-09 | １ｈ−インダゾール類、ベンゾチアゾール類、１，２−ベンゾイソオキサゾール類、１，２−ベンゾイソチアゾール類、および／クロモン類と、それらの製造と用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7932248B2 (https=) |
| EP (1) | EP1963332A1 (https=) |
| JP (1) | JP2009514980A (https=) |
| KR (1) | KR20080067339A (https=) |
| CN (1) | CN101316849A (https=) |
| AU (1) | AU2006311422A1 (https=) |
| BR (1) | BRPI0619672A2 (https=) |
| CA (1) | CA2627089A1 (https=) |
| IL (1) | IL190874A0 (https=) |
| WO (1) | WO2007056582A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007538011A (ja) * | 2004-05-07 | 2007-12-27 | メモリー・ファーマシューティカルズ・コーポレイション | １ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用 |
| PE20061119A1 (es) | 2005-01-19 | 2006-11-27 | Aventis Pharma Sa | PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie |
| FR2889526B1 (fr) | 2005-08-04 | 2012-02-17 | Aventis Pharma Sa | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
| CN101910170A (zh) * | 2007-10-22 | 2010-12-08 | 记忆药物公司 | 用于治疗疾病的烟碱性乙酰胆碱受体的(1,4-二氮杂双环[3.2.2]壬-6-烯-4-基)-杂环基-甲酮配体 |
| JO3250B1 (ar) | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
| CU24152B1 (es) | 2010-12-20 | 2016-02-29 | Irm Llc | 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr |
| EP2548870A1 (en) * | 2011-07-20 | 2013-01-23 | Cytec Technology Corp. | Process for the Synthesis of Cyclic Alkylene Ureas |
| EP2548869A1 (en) * | 2011-07-20 | 2013-01-23 | Cytec Technology Corp. | Process for the Synthesis of N-substituted Cyclic Alkylene Ureas |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| JP6064062B2 (ja) | 2013-03-15 | 2017-01-18 | ファイザー・インク | Ａｍｐｋを活性化させるインダゾール化合物 |
| CN106279119B (zh) * | 2015-05-27 | 2020-06-16 | 上海海和药物研究开发有限公司 | 一种新型激酶抑制剂的制备及其应用 |
| CN116462666B (zh) | 2017-01-10 | 2025-07-15 | 瑞士苏黎世联邦理工学院 | 细胞保护性化合物及其用途 |
| WO2022125377A1 (en) * | 2020-12-08 | 2022-06-16 | Disarm Therapeutics, Inc. | Benzopyrazole inhibitors of sarm1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
| MXPA05003317A (es) * | 2002-09-25 | 2005-07-05 | Memory Pharm Corp | Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos. |
| US7456171B2 (en) * | 2002-10-08 | 2008-11-25 | Sanofi-Aventis | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| FR2845388B1 (fr) * | 2002-10-08 | 2004-11-12 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique |
| DE602004010299T2 (de) * | 2003-12-22 | 2008-09-18 | Memory Pharmaceuticals Corp. | Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen |
| NZ550534A (en) * | 2004-03-25 | 2009-07-31 | Memory Pharm Corp | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
-
2006
- 2006-11-09 WO PCT/US2006/043818 patent/WO2007056582A1/en not_active Ceased
- 2006-11-09 JP JP2008540217A patent/JP2009514980A/ja active Pending
- 2006-11-09 AU AU2006311422A patent/AU2006311422A1/en not_active Abandoned
- 2006-11-09 US US11/594,993 patent/US7932248B2/en not_active Expired - Fee Related
- 2006-11-09 KR KR1020087011073A patent/KR20080067339A/ko not_active Ceased
- 2006-11-09 BR BRPI0619672-1A patent/BRPI0619672A2/pt not_active IP Right Cessation
- 2006-11-09 CN CNA2006800420321A patent/CN101316849A/zh active Pending
- 2006-11-09 CA CA002627089A patent/CA2627089A1/en not_active Abandoned
- 2006-11-09 EP EP06837344A patent/EP1963332A1/en not_active Withdrawn
-
2008
- 2008-04-15 IL IL190874A patent/IL190874A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6218260B2 (ja) | Ｊａｋ阻害剤としてのアミノピリミジニル化合物 | |
| JP6435323B2 (ja) | 炎症性障害の治療のための新規化合物及びその医薬組成物 | |
| CN105102451B (zh) | N-苯基-氨甲酰衍生物及其作为药物用于治疗乙型肝炎的用途 | |
| JP2009514980A5 (https=) | ||
| ES2616679T3 (es) | Nuevos derivados de indolizina, procedimiento para su preparación y composiciones farmacéuticas que los contienen para el tratamiento del cáncer | |
| JP6585158B2 (ja) | ヤヌスキナーゼの阻害に有用なピロロ［２，３−ｄ］ピリミジン誘導体 | |
| JP5785189B2 (ja) | Ｃ型肝炎ウイルス阻害剤 | |
| RU2399620C2 (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2450003C2 (ru) | Индазолы, бензотиазолы, бензоизотиазолы, бензоизоксазолы, пиразолопиридины, изотиазолопиридины, их получение и их применение | |
| JP2020164542A (ja) | Ｊａｋ阻害剤である５−クロロ−２−ジフルオロメトキシフェニルピラゾロピリミジン化合物 | |
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| CN106661017B (zh) | 二环性或三环性杂环化合物 | |
| TWI865582B (zh) | [1,2,4]三唑并[1,5-c]喹唑啉-5-胺 | |
| JP2008525526A5 (https=) | ||
| JP7250011B2 (ja) | Ｐ２ｘ３阻害剤としての新規なピラゾロ－ピロロ－ピリミジン－ジオン誘導体 | |
| KR20200088345A (ko) | B-raf 키나제 억제제의 결정성 염 | |
| JP2012501312A5 (https=) | ||
| RU2009120229A (ru) | Производные хинуклидинола в качестве антагонистов мускариновых рецепторов | |
| JP2025540958A (ja) | 蕁麻疹の治療のための野生型ｃ－ｋｉｔキナーゼ阻害剤としてのＮ－フェニル－ピラゾロ［１，５－Ａ］ピリジン－３－カルボキサミド誘導体 | |
| JP2009507758A5 (https=) | ||
| JP2013533868A (ja) | タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用 | |
| RU2019123319A (ru) | Пиразолопиримидины и способы их применения | |
| JP2020526549A5 (https=) | ||
| JPWO2021076602A5 (https=) | ||
| EP3980412A2 (en) | 1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof |